Asana, Inc.: Form 10-Q for the period ended Oct 31, 2023
Filed with the SEC on Dec 5, 2023 and accepted by EDGAR at Dec 5, 2023, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-08-01 to 2023-10-31 | $166.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-02-01 to 2023-10-31 | $481.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-08-01 to 2023-10-31 | $16.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-02-01 to 2023-10-31 | $47.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-08-01 to 2023-10-31 | $150.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-02-01 to 2023-10-31 | $434.2m | us-gaap:GrossProfit |
| Research and development | 3 months2023-08-01 to 2023-10-31 | $81.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-02-01 to 2023-10-31 | $241.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-08-01 to 2023-10-31 | −$63.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-02-01 to 2023-10-31 | −$202.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-08-01 to 2023-10-31 | $1.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-02-01 to 2023-10-31 | $2.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-08-01 to 2023-10-31 | $796.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-02-01 to 2023-10-31 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-08-01 to 2023-10-31 | −$61.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-02-01 to 2023-10-31 | −$194.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-08-01 to 2023-10-31 | −$0.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-02-01 to 2023-10-31 | −$0.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-08-01 to 2023-10-31 | −$0.28 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-02-01 to 2023-10-31 | −$0.89 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-08-01 to 2023-10-31 | 221,776,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-02-01 to 2023-10-31 | 219,094,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-02-01 to 2023-10-31 | −$2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-02-01 to 2023-10-31 | $7.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-02-01 to 2023-10-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-10-31 | $268.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-10-31 | $644.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-10-31 | $947.7m | us-gaap:Assets |
| Current liabilities | At period end2023-10-31 | $343.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-10-31 | $615.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-10-31 | $332.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477720-23-000053. Last ingested by Listed: Nov 11, 2026, 01:11 ET. Listed shows no prices and gives no investment advice.